J. Jefferson Smith - 01 Sep 2022 Form 3 Insider Report for PRECISION BIOSCIENCES INC (DTIL)

Role
Chief Research Officer
Signature
/s/ Dario Scimeca, Attorney-in-Fact for J. Jefferson Smith
Issuer symbol
DTIL
Transactions as of
01 Sep 2022
Net transactions value
$0
Form type
3
Filing time
09 Sep 2022, 07:16:45 UTC
Next filing
24 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding DTIL Common Stock 1,902,474 01 Sep 2022 Direct
holding DTIL Common Stock 237,959 01 Sep 2022 By Charitable Remainder Unitrust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding DTIL Employee Stock Option (Right to Buy) 01 Sep 2022 Common Stock 23,422 $1.18 Direct F1
holding DTIL Employee Stock Option (Right to Buy) 01 Sep 2022 Common Stock 46,845 $11.98 Direct F2
holding DTIL Employee Stock Option (Right to Buy) 01 Sep 2022 Common Stock 35,786 $5.83 Direct F3
holding DTIL Employee Stock Option (Right to Buy) 01 Sep 2022 Common Stock 25,118 $11.34 Direct F4
holding DTIL Restricted Stock Units 01 Sep 2022 Common Stock 9,744 Direct F5, F6
holding DTIL Employee Stock Option (Right to Buy) 01 Sep 2022 Common Stock 74,197 $4.08 Direct F7
holding DTIL Restricted Stock Units 01 Sep 2022 Common Stock 46,720 Direct F6, F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Stock options are fully vested as of the date of this report.
F2 The option vested as to 25% of the underlying shares on September 28, 2019 and thereafter in twelve substantially equal installments at the end of each three-month period over the 36 months following such date, subject to the Reporting Person's continued service to the Company through the applicable vesting dates.
F3 The option vested as to 25% of the underlying shares on April 1, 2021 and thereafter in twelve substantially equal installments at the end of each three-month period over the 36 months following such date, subject to the Reporting Person's continued service to the Company through the applicable vesting dates.
F4 The option vested as to 25% of the underlying shares on June 7, 2022 and thereafter in twelve substantially equal installments at the end of each three-month period over the 36 months following such date, subject to the Reporting Person's continued service to the Company through the applicable vesting dates.
F5 The restricted stock units ("RSUs") vest in three substantially equal annual installments beginning on June 7, 2022, subject to the Reporting Person's continued service to the Company through the applicable vesting dates.
F6 The Reporting Person was granted RSUs, which each represents a contingent right to receive one share of the Company's Common Stock.
F7 The option vests as to 25% of the underlying shares on March 3, 2023 and thereafter in twelve substantially equal installments at the end of each three-month period over the 36 months following such date, subject to the Reporting Person's continued service to the Company through the applicable vesting dates.
F8 The RSUs vest in three substantially equal annual installments beginning on March 3, 2023, subject to the Reporting Person's continued service to the Company through the applicable vesting dates.

Remarks:

Exhibit List: Exhibit 24 Power of Attorney